Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Takeda Pharmaceutical Li...

    OTC: TKPHF · Real-Time Price · USD
    28.27
    0.36 (1.29%)
    At close: Jun 12, 2025, 3:08 PM

    Takeda Pharmaceutical Statistics

    Share Statistics

    Takeda Pharmaceutical has 1.57B shares outstanding. The number of shares has increased by 1.03% in one year.

    Shares Outstanding

    n/a
    		 1.57B

    Shares Change (YoY)

    n/a
    		 1.03%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 1.51B

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 2.11M, so 0.14% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.11M

    Short % of Shares Out

    n/a
    		 0.14%

    Short % of Float

    n/a
    		 0.14%

    Short Ratio (days to cover)

    n/a
    		 147.8

    Valuation Ratios

    The PE ratio is 45.96 and the forward PE ratio is 0.16. Takeda Pharmaceutical's PEG ratio is -0.84.

    PE Ratio

    n/a
    		 45.96

    Forward PE

    n/a
    		 0.16

    PS Ratio

    n/a
    		 1.55

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 0.91

    P/FCF Ratio

    n/a
    		 28.1

    PEG Ratio

    n/a
    		 -0.84
    Financial Ratio History

    Enterprise Valuation

    Takeda Pharmaceutical has an Enterprise Value (EV) of 11,626.9B.

    EV / Sales

    n/a
    		 2.73

    EV / EBITDA

    n/a
    		 12.91

    EV / EBIT

    n/a
    		 16.23

    EV / FCF

    n/a
    		 49.35

    Financial Position

    The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.75.

    Current Ratio

    n/a
    		 1.11

    Quick Ratio

    n/a
    		 0.58

    Debt / Equity

    n/a
    		 0.75

    Debt / EBITDA

    n/a
    		 6.07

    Debt / FCF

    n/a
    		 23.19

    Interest Coverage

    n/a
    		 1.79

    Financial Efficiency

    Return on Equity is 1.98% and Return on Invested Capital is 4.42%.

    Return on Equity

    n/a
    		 1.98%

    Return on Assets

    n/a
    		 0.95%

    Return on Invested Capital

    n/a
    		 4.42%

    Revenue Per Employee

    n/a
    		 $86,519,388.81

    Profits Per Employee

    n/a
    		 $2,923,378.18

    Employee Count

    n/a
    		 49,281

    Asset Turnover

    n/a
    		 0.28

    Inventory Turnover

    n/a
    		 1.18

    Taxes

    Income Tax

    n/a
    		 -91.41B

    Effective Tax Rate

    n/a
    		 -173.15%

    Stock Price Statistics

    The stock price has increased by 5.37% in the last 52 weeks. The beta is 0.26, so Takeda Pharmaceutical's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.26

    52-Week Price Change

    n/a
    		 5.37%

    50-Day Moving Average

    n/a
    		 28.55

    200-Day Moving Average

    n/a
    		 27.8

    Relative Strength Index (RSI)

    n/a
    		 52.58

    Average Volume (20 Days)

    n/a
    		 13,631

    Income Statement

    In the last 12 months, Takeda Pharmaceutical had revenue of 4,263.8B and earned 144.07B in profits. Earnings per share was 92.09.

    Revenue

    n/a
    		 4,263.8B

    Gross Profit

    n/a
    		 2,832.3B

    Operating Income

    n/a
    		 214.07B

    Net Income

    n/a
    		 144.07B

    EBITDA

    n/a
    		 900.33B

    EBIT

    n/a
    		 172.33B

    Earnings Per Share (EPS)

    n/a
    		 92.09
    Full Income Statement

    Balance Sheet

    The company has 457.8B in cash and 5,463.4B in debt, giving a net cash position of -5,005.6B.

    Cash & Cash Equivalents

    n/a
    		 457.8B

    Total Debt

    n/a
    		 5,463.4B

    Net Cash

    n/a
    		 -5,005.6B

    Retained Earnings

    n/a
    		 1,391.2B

    Total Assets

    n/a
    		 15,106.8B

    Working Capital

    n/a
    		 656.32B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 716.34B and capital expenditures -480.73B, giving a free cash flow of 235.61B.

    Operating Cash Flow

    n/a
    		 716.34B

    Capital Expenditures

    n/a
    		 -480.73B

    Free Cash Flow

    n/a
    		 235.61B

    FCF Per Share

    n/a
    		 150.61
    Full Cash Flow Statement

    Margins

    Gross margin is 66.43%, with operating and profit margins of 5.02% and 3.38%.

    Gross Margin

    n/a
    		 66.43%

    Operating Margin

    n/a
    		 5.02%

    Pretax Margin

    n/a
    		 1.24%

    Profit Margin

    n/a
    		 3.38%

    EBITDA Margin

    n/a
    		 21.12%

    EBIT Margin

    n/a
    		 5.02%

    FCF Margin

    n/a
    		 5.53%

    Dividends & Yields

    TKPHF pays an annual dividend of $1.95, which amounts to a dividend yield of 4.24%.

    Dividend Per Share

    n/a
    		 $1.95

    Dividend Yield

    n/a
    		 4.24%

    Dividend Growth (YoY)

    n/a
    		 5.1%

    Payout Ratio

    n/a
    		 415.47%

    Earnings Yield

    n/a
    		 2.18%

    FCF Yield

    n/a
    		 3.56%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for TKPHF.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $2302.25

    Lynch Upside

    n/a
    		 8043.79%

    Graham Number

    n/a
    		 3103.68

    Graham Upside

    n/a
    		 10878.71%

    Scores

    Altman Z-Score

    n/a
    		 0.55

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist